Research Article
Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of ICU-Hospitalized COVID-19 Patients
Table 1
Demographics and baseline characteristics of patients.
| | Overall (N = 391) | General data | N | % |
| Age | ≤60 y | 156 | 39.9 | >60 y | 235 | 60.1 |
| Sex | Male | 224 | 57.3 | Female | 167 | 42.7 |
| O2Sat, baseline | O2 < 88% | 316 | 80.8 | | 92% > O2 ≥ 88% | 59 | 15.1 | O2 ≥ 92% | 16 | 4.1 |
| Comorbidities | HTN | 162 | 41.4 | DM | 156 | 39.9 | IHD | 82 | 21 | CKD | 81 | 20.7 | COPD | 54 | 13.8 | CVA | 40 | 10.2 | DLP | 38 | 9.7 | ESRD | 24 | 6.1 | Brain hemorrhage | 23 | 5.9 | Cancer | 12 | 3.1 | Hypothyroidism | 9 | 2.3 | Seizure | 9 | 2.3 | IPF | 7 | 1.8 | Cirrhosis | 5 | 1.3 | Trauma | 3 | 0.8 | Parkinson | 3 | 0.8 | Rheumatoid arteritis | 2 | 0.5 | Sickle cell | 2 | 0.5 | MS | 2 | 0.5 | LAM | 1 | 0.3 |
| Imaging result (score of lung involvement) at baseline | Mild (0–8) | 81 | 20.7 | Moderate (9–16) | 168 | 43 | Severe (17–25) | 142 | 36.3 |
| Type of CT involvement | Consolidation | 133 | 34 | GGO | 100 | 25.6 | Mix | 44 | 11.25 | Reticular + Fibrosis | 35 | 8.95 | PE | 33 | 8.40 | Nodular | 23 | 5.90 | Crazy paving | 23 | 5.90 |
| Laboratory findings | CRP | Negative | 78 | 19.9 | + | 77 | 19.7 | ++ | 131 | 33.5 | +++ | 105 | 26.9 | WBC | WBC<4000 | 44 | 11.26 | WBC: 4000–10000 | 219 | 56.01 | WBC>10000 | 128 | 32.73 | | Mean ± SD | WBC | 9.27 ± 5.58 | ESR | 46.05 ± 28.81 | CPK | 396.19 ± 678.29 | LDH | 711.39 ± 414.09 | NLR | 10.39 ± 8.66 | RBC | 4.82 ± 0.78 | AST | 71.61 ± 136.86 | ALT | 63.96 ± 128.31 | ALP | 215.08 ± 121.98 | PLT | 203.44 ± 91.81 | Cr | 1.76 ± 1.89 | BUN | 60.98 ± 51.89 |
|
|
N: number; SD: standard deviation; DM: diabetes mellitus; HTN: hypertension; IHD: ischemic heart disease; DLP: dyslipidemia; COPD: chronic obstructive pulmonary disease; CVA: cerebral vascular accident; ESRD: end stage renal disease; IPF: idiopathic pulmonary fibrosis; MS: multiple sclerosis; LAM: lymphangioleiomyomatosis; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; CPK: creatine phosphokinase; LDH: lactate dehydrogenase; WBC: white blood cells; NLR: neutrophil-lymphocyte ratio; AST: aspartate transaminase; ALT: alanine transaminase; ALP: alkaline phosphatase; O2Sat: oxygen saturation; Cons: considerations; GGO: ground-glass opacification; PE: pleural effusion; y: year.
|